LCC Therapeutics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 24

Employees

  • Latest Deal Type
  • Bankr. Admin/​Reorg

LCC Therapeutics General Information

Description

Developer of chiral small molecules intended to aid in biotech and pharmaceutical research. The company's molecules can be used as building blocks, fragments, and intermediates, which are important for drug discovery and development due to pharmacokinetic properties, enabling the pharmaceutical industry to have a continual feedstock of new drug molecules.

Contact Information

Website
www.liverpoolchirochem.com
Formerly Known As
Liverpool ChiroChem
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • The Heath Business & Technical Park
  • Runcorn WA7 4QX
  • England, United Kingdom
+44 01928
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Parent Company
XtalPi Technology
Vertical(s)
Life Sciences
Corporate Office
  • The Heath Business & Technical Park
  • Runcorn WA7 4QX
  • England, United Kingdom
+44 01928

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LCC Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Bankruptcy: Admin/Reorg 17-Jun-2025 Completed Bankruptcy: Admin/Reorg
9. Merger/Acquisition 12-Jun-2025 Completed Generating Revenue
8. Later Stage VC 22-Dec-2023 Completed Generating Revenue
7. Later Stage VC 13-Apr-2021 Completed Generating Revenue
6. Later Stage VC 27-Sep-2019 Completed Generating Revenue
5. Secondary Transaction - Private Completed Startup
4. Early Stage VC 05-Apr-2018 Completed Startup
3. Early Stage VC 10-Nov-2015 Completed Startup
2. Grant 09-Jul-2015 $15.5K Completed Startup
1. University Spin-Out 18-Feb-2014 Completed Startup
To view LCC Therapeutics’s complete valuation and funding history, request access »

LCC Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
A4 Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 9,652,662 $0.001263 $0.23 $0.23 1x $0.23 12.08%
Ordinary 9,047,859 $0.001263 $0.15 $0.15 1x $0.15 11.33%
To view LCC Therapeutics’s complete cap table history, request access »

LCC Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of chiral small molecules intended to aid in biotech and pharmaceutical research. The company's molecules can
Biotechnology
Runcorn, United Kingdom
24 As of 2025

Loughborough, United Kingdom
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

LCC Therapeutics Competitors (3)

One of LCC Therapeutics’s 3 competitors is Charnwood Discovery, a Private Equity-Backed company based in Loughborough, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Charnwood Discovery Private Equity-Backed Loughborough, United Kingdom
Lite Strategy Corporation San Diego, CA
Enamine Corporation Kyiv, Ukraine
You’re viewing 3 of 3 competitors. Get the full list »

LCC Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

LCC Therapeutics Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Deepbridge Capital Venture Capital Minority
Government of UK Government Minority
Maven Capital Partners UK PE/Buyout Minority
Mercia Ventures Venture Capital Minority
Merseyside Innovation Awards Corporation
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

LCC Therapeutics FAQs

  • When was LCC Therapeutics founded?

    LCC Therapeutics was founded in 2014.

  • Where is LCC Therapeutics headquartered?

    LCC Therapeutics is headquartered in Runcorn, United Kingdom.

  • What is the size of LCC Therapeutics?

    LCC Therapeutics has 24 total employees.

  • What industry is LCC Therapeutics in?

    LCC Therapeutics’s primary industry is Biotechnology.

  • Is LCC Therapeutics a private or public company?

    LCC Therapeutics is a Private company.

  • What is LCC Therapeutics’s current revenue?

    The current revenue for LCC Therapeutics is .

  • How much funding has LCC Therapeutics raised over time?

    LCC Therapeutics has raised $18.1M.

  • Who are LCC Therapeutics’s investors?

    Deepbridge Capital, Government of UK, Maven Capital Partners UK, Mercia Ventures, and Merseyside Innovation Awards are 5 of 8 investors who have invested in LCC Therapeutics.

  • Who are LCC Therapeutics’s competitors?

    Charnwood Discovery, Lite Strategy, and Enamine are competitors of LCC Therapeutics.

  • When was LCC Therapeutics acquired?

    LCC Therapeutics was acquired on 17-Jun-2025.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process